Summary.-The effect of 16,16-dimethyl-PGE2-methyl ester (di-M-PGE2), a longacting synthetic analogue of prostaglandin E2, on the replication of Friend erythroleukaemia cells (FLC) in vivo has been studied. Pre-treatment in vitro of both undifferentiated and differentiated FLC with di-M-PGE2 (1 jug/ml) did not alter rates of tumour appearance or growth, but increased the median survival of DBA/2J mice.
PROSTAGLANDINS of the E series are known to inhibit the growth of a number of tumour cell lines (Hamprecht et al., 1973; Thomas et al., 1974) in vitro. In previous studies we demonstrated that 16,1 6-dimethyl-PGE2-methyl ester (di-M-PGE2), a long-acting synthetic analogue of PGE2, profoundly inhibited the growth of B16 melanoma both in vitro and in vivo (Santoro et al., 1976; 1977a) . PGEs have also been shown to induce differentiation in some tumour-cell lines, including neuroblastomas (Prasad, 1972a and b) and mouse fibroblasts (Johnson & Pastan, 1971) .
Murine erythroleukaemia cells infected with the Friend virus (FLC) differentiate in vitro from a proerythroblast-like to a normoblast-like stage producing haemoglobin when they are treated with dimethylsulfoxide (DMSO) or other inducers (Friend et al., 1971; Leder & Leder, 1975; Reuben et al., 1976; Ebert et al., 1976) . Chemically induced differentiation is promptly and spontaneously reversed when the inducing agents are removed from the culture medium (Friend et al., 1971 ).
The i.v. inoculation of cultured FLC into DBA/2J mice produces malignant disease, characterized by leukaemic-cell infiltration of marrow, lymph nodes, liver and spleen (Preisler et al., 1976) whilst s.c. administration produces s.c. tumours similar to myeloblastomas, which cause the death of the animals within a 3-7-week period. Inoculation of mice with FLC pretreated in vitro with DMSO for at least 72 h produces smaller tumours and permits longer survival than untreatedcell inocula (Friend et al., 1971; Preisler et al., 1976) . In a recent study we demonstrated that endogenously synthesized PGE was involved in the regulation of the proliferation and differentiation of FLC in vitro (Santoro et al., 1979) . Moreover, the addition of the long-acting analogue di-M-PGE2 to the culture medium pro-fouiidly inhibited the growth and stimulated the differentiation (measured as haemoglobin production) of DMSO-treated cells. The effect of prostaglandins Aas reversible; haemoglobin synthesis started to decrease shortly after removal of di-M-PG'E2 from the culture medium, reaching control values after 14 duplication cycles. In the current study we Crosby & Furth (1956) . Lysis of cells wsas obtained by repeated (3 x ) freeze-thawings of pellets of cells (2 x 106 cells) that hlad been wa,shed twice in sterile 0-90 NaCl.
Eighty nine 4-month-old male DBA/2J illice wrere weighed, shaved and injected s.c. in the right flank with 0-2 ml of sterile medium containing 0 5 or l Ox 106 viable FLC. Mice were examined daily by palpation for tumour appearcance, and when the tumours became measurable (at least 2 mm in diameter) they were measured daily in at least 2 dimensions by Vernier caliper. The average of the smnallest and largest diameters wNas calculated. Statistical comparisons used a t test for unpaired data; P values of <0 05 were considered significant. Curves of rates of appearance of tumours and survival were compared with the use of the sign test (Dixon & Massey, 1957) and a values of <0 (05 were A. The rate of tumour appearance. In both DMSO and DMSO + di-M-PGE2 groups the appearance of tumours was significantly delayed as compared to control (cx < 0.-004). B. Mouse survival data. Percent survival was significantly increased in di-M-PGE2 (04< 0.02), DMSO (a<0.-0.01), and di-M-PGE2-4DMSO (cw<0-001) groups as compared to control.
Injections were repeated daily, s.c. in 50o) weight change compared to other the tumour area from Days I to 5, and treatment groups. The rate of tumour i.p. from Days 6 to 21, to avoid direct appearance is illustrated in Fig. 2A . 2 received undifferentiated cells. Di-M-PGE2 treatment did not significantly alter tumour appearance in mice injected with control cells, while it greatly delayed the appearance of tumours in mice that received DMSO-treated cells (oc<0OOl compared to both control and DMSO-control). Two mice (17%) of this last group did not get visible tumours, and these were the only animals not to develop tumours. After appearance, tumours grew rapidly in a rather uniform spherical shape. Mean tumour diameters are shown in Fig. 3A . Because some of the tumours (particularly in Group IV) were too small to be measured, they were not included in the growthrate data presented in Fig. 3A ; the percent of measurable tumours (>2 mm diameter) used in the calculations is plotted in Fig. 3B . These data clearly show that tumours derived by DMSO-pretreated cells grow more slowly than those from undifferentiated cells. Furthermore, di-M-PGE2 treatment profoundly inhibited the rates of tumour growth, particularly in mice injected with differentiated cells.
In fact, until Day 17, 50% of the tumours in this group were immeasurable (<2 mm in diameter).
The survival data are presented in (and in some mice completely prevented) the appearance of tumours. Since thiu effect was not seen in mice inoculated with undifferentiated cells, the data suggesi that di-M-PGE2 acts directly on the replication of tumour cells, rather than on factors related to host response. It is interesting that the in vitro studies (Santoro et al., 1979 ) also demonstrated thai DMSO-treated FLC are much more sensitive to di-M-PGE2 than undifferentiated cells. In fact, the latter were not affected by di-M-PGE2, even at higher concentrations (50 jg/ml).
The antitumour effect of di-M-PGE2-treatment in vivo cannot be due to increased host immunological response. In fact, prostaglandins of the E series are known to be immunosuppressive. The same dose of di-M-PGE2 has been shown to prolong the survival of mouse skin allografts (Anderson & Jaffe, 1974) and hamster-to-rat heart xenografts (Kakita et al., 1975) . In the B16 melanoma studies in vivo we showed that daily administration of the same dose of di-M-PGE2 did not produce changes in the density (mg/ mm3) or the number of inflammatory celil in the tumours nor in any histological aspect of the tumour (Santoro et al., 1977b) In fact, the only difference noted was a dose-related decrease in mitotic index. These observations further support the hypothesis that di-M-PGE2 acts directly on tumour-cell replication rather than on host factors. Further study is necessary to investigate the specific mechanisms of the growth-inhibitory actions of PGE.
